Inhibition of cytochrome P450 3A4 activity by schisandrol A and gomisin A isolated from Fructus Schisandrae chinensis

scientific article published on 25 January 2010

Inhibition of cytochrome P450 3A4 activity by schisandrol A and gomisin A isolated from Fructus Schisandrae chinensis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.PHYMED.2009.12.005
P698PubMed publication ID20089387

P50authorGuo-Yuan ZhuQ39607293
P2093author name stringH Wang
A K Tse
C-K Wan
D W F Fong
Z-L Yu
P433issue8-9
P304page(s)702-705
P577publication date2010-01-25
P1433published inPhytomedicineQ7189797
P1476titleInhibition of cytochrome P450 3A4 activity by schisandrol A and gomisin A isolated from Fructus Schisandrae chinensis
P478volume17

Reverse relations

cites work (P2860)
Q91980588A Strategy for Selecting "Q-Markers" of Chinese Medical Preparation via Components Transfer Process Analysis with Application to the Quality Control of Shengmai Injection
Q35588216Anti-inflammatory effect of heme oxygenase-1 toward Porphyromonas gingivalis lipopolysaccharide in macrophages exposed to gomisins A, G, and J.
Q46388926Comparative Phytochemical Analysis of Chinese and Bay Starvine (Schisandra spp.): Potential for Development as a New Dietary Supplement Ingredient.
Q37736045Current knowledge of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) as a medicinal plant species: a review on the bioactive components, pharmacological properties, analytical and biotechnological studies.
Q35086810Isolation and purification of schisandrol A from the stems of Schisandra chinensis and cytotoxicity against human hepatocarcinoma cell lines
Q34171741P-Glycoprotein- and cytochrome P-450-mediated herbal drug interactions
Q48162273Time- and NADPH-Dependent Inhibition on CYP3A by Gomisin A and the Pharmacokinetic Interactions between Gomisin A and Cyclophosphamide in Rats.
Q59799864Utilization of Chinese medicine for respiratory discomforts by patients with a medical history of tuberculosis in Taiwan
Q36675148YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α.

Search more.